Clinical Trials Directory

Trials / Conditions / Adult Pure Erythroid Leukemia

Adult Pure Erythroid Leukemia

9 registered clinical trials studyying Adult Pure Erythroid Leukemia.

StatusTrialSponsorPhase
CompletedCytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia
NCT01870596
National Cancer Institute (NCI)Phase 2
CompletedTipifarnib in Treating Older Patients With Acute Myeloid Leukemia
NCT01361464
National Cancer Institute (NCI)Phase 2
TerminatedAzacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute My
NCT01260714
National Cancer Institute (NCI)Phase 1
CompletedBusulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacit
NCT01168219
National Cancer Institute (NCI)Phase 2
Active Not RecruitingAzacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leuke
NCT00658814
National Cancer Institute (NCI)Phase 2
CompletedVeliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leu
NCT00588991
National Cancer Institute (NCI)Phase 1
CompletedTipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Ph
NCT00383474
National Cancer Institute (NCI)Phase 1
CompletedSorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blast
NCT00217646
National Cancer Institute (NCI)Phase 1
CompletedTipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
NCT00093470
National Cancer Institute (NCI)Phase 3